LOVD - Variant listings for RPS19

About this overview [Show]

Patient data (#0000087)
Patient ID pat6rps1900028
Gender na
Malformations Not available
Growth Retardation na
Steroid Response na
Complications -
Variant Origin sporadic?(parents not tested)
Reference Gazda et al (2004) Br J Haematol 127, 105-13
Template DNA
Technique SEQ
Remarks -
# Reported 1

Variant data
Allele Unknown
Reported pathogenicity Pathogenic
Concluded pathogenicity Pathogenic
Exon 04
DNA change c.185G>A   (View in UCSC Genome Browser, Ensembl)
RNA change -
Protein p.Arg62Gln
Frequency -
DB-ID RPS19_00028
Location -
Remarks Missense mutation; Leucine not effective in increasing translational efficiency in lymphocytes.
Molecula Mechanisms CpG
Functional_Classific Impairs ribosomal association but not nucleolar localization
mRNA_Expression -
Protein_Expression Apparently normal protein levels. Intermediate stability (HEK293) [1]
Protein_Localization Nucleolar localization, but no ribosome association (HeLa-HEK293) [1]. It alters the ultrastructural nucleolar organization in dermal fibroblasts [2]
rRNA_Metabolism 18S rRNA processing defect both in yeast (orthologue mutation: p.Arg63Gln) and in human dermal fibroblasts, as indicated by increase in 21S pre-rRNA [2,3]. Accumulation of 45S and 41S precursors is observed in dermal fibroblasts [2]; yeast cells show nucleolar accumulation of pre-40S particles [3]
Protein_Synthesis Translation rate reduced to 56% of controls after transfection in K562 cells [4]. In lymphocytes, translation is reduced to 66% of controls in basal conditions and to 62% after PHA activation [4]
Cell_Growth The human mutation impairs growth of skin fibroblasts [2] and the yeast orthologue mutation (p.Arg63Gln) impairs but does not abolish cell growth in yeast [3]
Functional_Remarks translation was found reduced in lymphocytes from all the DBA subjects studied irrespective of the presence of RPS19 mutations [4]
Functional_Reference [1] Angelini et al (2007) Hum Mol Genet 16, 1720-7; [2]Choesmel et al (2007) Blood 109, 1275-83; [3] Léger-Silvestre et al (2005) J Biol Chem 280, 38177-85; [4] Cmejlova et al (2006) Haematologica 91, 1456-64

1 entry in RPS19

Path.
Allele Descending
Ascending
Exon Descending
Ascending
DNA change Descending
Ascending
RNA change Descending
Ascending
Protein Descending
Ascending
Frequency Descending
Ascending
DB-ID Descending
Ascending
Location Descending
Ascending
Remarks Descending
Ascending
Molecula Mechanisms Descending
Ascending
Functional_Classific Descending
Ascending
mRNA_Expression Descending
Ascending
Protein_Expression Descending
Ascending
Protein_Localization Descending
Ascending
rRNA_Metabolism Descending
Ascending
Protein_Synthesis Descending
Ascending
Cell_Growth Descending
Ascending
Functional_Remarks Descending
Ascending
Functional_Reference Descending
Ascending
+/+ Unknown 04 c.185G>A - p.Arg62Gln - RPS19_00028 - Missense mutation; Leucine not effective in increasing translational efficiency in lymphocytes. CpG Impairs ribosomal association but not nucleolar localization - Apparently normal protein levels. Intermediate stability (HEK293) [1] Nucleolar localization, but no ribosome association (HeLa-HEK293) [1]. It alters the ultrastructural nucleolar organization in dermal fibroblasts [2] 18S rRNA processing defect both in yeast (orthologue mutation: p.Arg63Gln) and in human dermal fibroblasts, as indicated by increase in 21S pre-rRNA [2,3]. Accumulation of 45S and 41S precursors is observed in dermal fibroblasts [2]; yeast cells show nucleolar accumulation of pre-40S particles [3] Translation rate reduced to 56% of controls after transfection in K562 cells [4]. In lymphocytes, translation is reduced to 66% of controls in basal conditions and to 62% after PHA activation [4] The human mutation impairs growth of skin fibroblasts [2] and the yeast orthologue mutation (p.Arg63Gln) impairs but does not abolish cell growth in yeast [3] translation was found reduced in lymphocytes from all the DBA subjects studied irrespective of the presence of RPS19 mutations [4] [1] Angelini et al (2007) Hum Mol Genet 16, 1720-7; [2]Choesmel et al (2007) Blood 109, 1275-83; [3] Léger-Silvestre et al (2005) J Biol Chem 280, 38177-85; [4] Cmejlova et al (2006) Haematologica 91, 1456-64